搜索
Addex Therapeutics Ltd
ADXN添加自选
5.790USD
+0.120+2.10%
收盘 07/02, 13:00（美东）报价延迟15分钟
5.76M总市值
亏损市盈率 TTM
关于 Addex Therapeutics Ltd 公司
Addex Therapeutics Ltd is a Switzerland-based clinical-stage pharmaceutical company. The Company focuses on development and commercialization of orally available small molecule drugs known as allosteric modulators for neurological disorders. The Company’s clinical programs pipeline include dipraglurant (mGlu5 NAM), which is Phase 2a placebo-controlled clinical trial for Parkinson's disease levodopa-induced dyskinesia (PD-LID), and is being prepared to enter registration trials for PD-LID, and ADX71149 (mGlu2 positive allosteric modulator or PAM), which is being developed in collaboration by its partner Janssen Pharmaceuticals, Inc to treat schizophrenia and anxious depression. It also is advancing several preclinical programs, including GABABPAM for pain, overactive bladder and other disorders, mGlu7 NAM for post-traumatic stress disorder, mGlu2 NAM for mild neurocognitive disorders, mGlu4 PAM for Parkinson’s disease and mGlu3 PAM for neurodegenerative disorders.
Addex Therapeutics Ltd简介
公司代码ADXN
公司名称Addex Therapeutics Ltd
上市日期May 22, 2007
CEODyer (Tim)
员工数量2
证券类型Depository Receipt
年结日May 22
公司地址Chemin des Mines, 9
城市PLAN-LES-OUATES
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Switzerland
邮编1202
电话41228841555
网址https://www.addextherapeutics.com/en/
公司代码ADXN
上市日期May 22, 2007
CEODyer (Tim)
Addex Therapeutics Ltd公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Tim Dyer
Mr. Tim Dyer
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
--
--
Dr. Raymond G. (Ray) Hill
Dr. Raymond G. (Ray) Hill
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Dr. Vincent Lawton
Dr. Vincent Lawton
Independent Non-Executive Chairman of the Board of Directors
Independent Non-Executive Chairman of the Board of Directors
--
--
Dr. Roger G. Mills
Dr. Roger G. Mills
Member of the Executive Management, Chief Medical Officer, Member of the Board of Directors
Member of the Executive Management, Chief Medical Officer, Member of the Board of Directors
--
--
Mr. Jake R. Nunn
Mr. Jake R. Nunn
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Dr. Isaac Manke
Dr. Isaac Manke
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Dr. Mikhail Kalinichev
Dr. Mikhail Kalinichev
Member of the Executive Management, Head of Translational Science
Member of the Executive Management, Head of Translational Science
--
--
Mr. Lenaic Teyssedou
Mr. Lenaic Teyssedou
Member of the Executive Management, Head of Finance
Member of the Executive Management, Head of Finance
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Tim Dyer
Mr. Tim Dyer
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
--
--
Dr. Raymond G. (Ray) Hill
Dr. Raymond G. (Ray) Hill
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Dr. Vincent Lawton
Dr. Vincent Lawton
Independent Non-Executive Chairman of the Board of Directors
Independent Non-Executive Chairman of the Board of Directors
--
--
Dr. Roger G. Mills
Dr. Roger G. Mills
Member of the Executive Management, Chief Medical Officer, Member of the Board of Directors
Member of the Executive Management, Chief Medical Officer, Member of the Board of Directors
--
--
Mr. Jake R. Nunn
Mr. Jake R. Nunn
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Dr. Isaac Manke
Dr. Isaac Manke
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
常见问题
Addex Therapeutics Ltd的前五大股东是谁？
Addex Therapeutics Ltd 的前五大股东如下：Mr. Tim Dyer
有多少机构持有Addex Therapeutics Ltd(ADXN)的股份？
截至2026Q1，共有8家机构持有Addex Therapeutics Ltd的股份，合计持有的股份价值约为454.00，占公司总股份的0.05%。与2025Q4相比，机构持股有所增加，增幅为-12676.00。